Mr. Francois Roberge reports

GROUPE LSL PHARMA ANNOUNCES NEW ORDERS WITH AN ANNUAL REVENUE POTENTIAL IN EXCESS OF $2.6 MILLION

LSL Pharma Group Inc.'s subsidiary, LSL Laboratory (LSL), has received new orders for natural health products.

These new orders reflect the addition of new clients, as well as volume increases from certain existing clients. In addition to benefits from the higher production capacity stemming from the relocation of LSL's activities to a new facility in La Pocatiere, the company's solid reputation enabled it to take advantage of favourable market conditions.

Based on purchase orders received up to this date, the company believes that the positive effect on its sales could exceed $2.6-million on an annual basis, beginning gradually in the first quarter of 2024.

In addition, LSL Pharma Group is engaged in negotiations for potential additional orders related to natural health products. Should all discussions be successful, these orders could result in annual sales of approximately $1.5-million.

"We are very pleased with these new orders that reflect our constant efforts to stimulate sales and that are in keeping with our strategic plan of increasing our reach in niche product categories," said Francois Roberge, president and chief executive officer of LSL Pharma Group. "With increased capacity, LSL is more actively seeking growth opportunities in its target markets, which enabled our subsidiary to capitalize on favourable market conditions to win new orders. Meanwhile, the new facility's production rate is ramping up in line with our expectations, and further volume growth next year will result in better fixed cost absorption, which should allow us to increase profitability."

About LSL Pharma Group Inc.

LSL Pharma Group is a Canadian integrated pharmaceutical company specializing in the development, manufacturing and distribution of high-quality natural health products and dietary supplements in solid dosage forms, as well as high-quality sterile ophthalmic pharmaceutical products.

We seek Safe Harbor.